¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"phase shift artifact"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • nuclear shift
    ÇÙÀ̵¿
  • proton shift
    ¾ç¼ºÀÚÀ̵¿
  • shift
    À̵¿, º¯À§
  • shift to the left
    ¿ÞÂÊÀ̵¿, ÁÂÃøÀ̵¿
  • temporary threshold shift
    ÀϽÃÀû¹®Åΰªº¯À§
  • zero-time shift
    ¿øÁ¡À̵¿
  • artifact
    1. Àΰø¹° 2. Çã»ó, ÀΰøÀ½¿µ
  • aliasing artifact
    µÑ·¯°ãħÇã»ó
  • beam-thickness artifact
    ¼±µÎ²²Çã»ó
  • beam-width artifact
    ºû»ìÆøÀΰø¹°
  • comet-tail artifact
    Çý¼º²¿¸®Çã»ó, Çý¼º²¿¸®Àΰø¹°
  • duplication artifact
    Áߺ¹Àΰø¹°, Áߺ¹Çã»ó
  • data clipping artifact
    ÀÚ·áÀý´ÜÀΰø¹°
  • ferromagnetic artifact
    °­ÀÚ¼ºÀΰø¹°
  • flow artifact
    È帧Àΰø¹°, È帧Çã»ó, À¯µ¿Àΰø¹°
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 7 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • resting phase
    È޽ıâ
  • solid phase
    °íü»ó
  • stance phase
    µðµõ±â, ÀÔ°¢±â
  • swing phase
    Èçµê±â, À¯°¢±â
  • synaptic phase
    ¿¬Á¢±â
  • expiratory phase time
    ³¯¼û½Ã°£, È£±â½Ã°£
  • inspiratory phase time
    µé¼û½Ã°£, Èí±â½Ã°£
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • isodose shift method
    µî¼±·®À̵¿¹ý
  • isohydric shift
    µî¼ö¼ÒÀ̵¿
  • left axis shift
    ¿ÞÃຯÀ§
  • midline shift
    Áß°£¼±ÀüÀ§
  • midline echo shift
    Á¤Áß¼±¸Þ¾Æ¸®º¯À§
  • stereo shift method
    Á¤À§À̵¿¹ý
  • nuclear shift
    ÇÙÀ̵¿
  • proton shift
    ¾ç¼ºÀÚÀ̵¿
  • ribosomal frame shift
    ¸®º¸¼ØÇص¶Æ²º¯ÀÌ
  • shift
    À̵¿, º¯À§
  • shift work
    ±³´ë±Ù¹«
  • temporary threshold shift
    ÀϽÃÀû¹®Åΰªº¯À§
  • zero-time shift
    ¿øÁ¡À̵¿
  • artifact
    Àΰø¹°, Çã»ó
  • aliasing artifact
    µÑ·¯°ãħÀΰø¹°
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • antigenic shift
    Ç׿ø´ëº¯ÀÌ
  • antigenic shift
    Ç׿øº¯ÀÌ
  • antigenic shift, influenza viruses
    Ç׿ø´ëº¯ÀÌ(¡­ÓÞܨì¶)
  • pivot shift test
    ÃßÃà º¯À§ ½ÃÇè
  • 3D phase contrast angiography
    3Â÷¿ø À§»ó ´ëÁ¶ Ç÷°üÁ¶¿µ¼ú
  • DNA synthetic phase
    DNA ÇÕ¼º±â
  • Go phase
    Go±â
  • accelerated death phase
    °¡¼Ó»ç¸ê±â(˧ËÛË×ËÎË»).
  • acceleration phase
    ÃËÁø±â, °¡¼Ó±â(Ê¥áÜÑ¢).
  • acute phase protein
    ±Þ¼ºº´±â´Ü¹éÁú
  • acute phase reactant
    ±Þ¼º±â ÀÛ¿ë¹°Áú
  • acute phase reaction
    ±Þ¼º±â¹ÝÀÀ(¡­Ñ¢Úãëë)
  • acute phase reactive protein
    ±Þ¼º±â ¹ÝÀÀ¼º ´Ü¹é.
  • acute phase serum
    ±Þ¼ºº´±âÇ÷û
  • acute phase substances
    ±Þ¼º±â ¹°Áú(ÐáàõÑ¢Úªòõ).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • chemical shift anisotropy
    È­ÇÐÀû º¯À§ ºñµî¹æ¼º
  • chemical shift imaging (CSI)
    È­ÇÐÀû º¯À§ ¿µ»ó
  • chemical shift selection (CHESS)
    È­ÇÐÀû º¯À§ ¼±ÅÃ
  • chloride shift
    ¿°¼Ò(ÀÌ¿Â)À̵¿(¡­ì¹ÔÑ)
  • false shift
    °¡¼º º¯À§
  • false shift
    °¡¼º À§µ¿ (Ê£àõ êÈÔÑ)
  • isodose shift factor
    µî¼±·®À̵¿°è¼ö
  • isodose shift method
    µî¼±·®À̵¿¹ý
  • isohydric shift
    µî¼ö¼Ò(ÆòÇü)À̵¿ (¡­øÁû¬ì¹ÔÑ).
  • left axis shift
    ÁÂÃຯÀ§.
  • midline echo shift
    Á¤Áß¼± ¿¡ÄÚ º¯À§
  • midline echo shift
    Á¤Áß¼± (ïáñéàÊ) ¿¡ÄÚ º¯À§ (ܨêÈ)
  • mutation, frame-shift
    ÇØµ¶Æ² µ¹¿¬º¯ÀÌ, ÇÁ·¹ÀÓ½¬ÇÁÆ® µ¹¿¬º¯ÀÌ
  • nuclear shift
    ÇÙÀ̵¿(Ì´ËöËÄ) ¹éÇ÷±¸ÀÇ .
  • permanent threshold shift
    ¿µ±¸Ã»·Â¼Õ½Ç
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • Postmenstrual phase
    ¿ù°æÈıâ
    [¿¾ ¿ë¾î] ¿ù°æÈıâ
  • Zygotene phase
    Á¢ÇÕ±â
    [¿¾ ¿ë¾î] Á¢ÇÕ±â
  • Go phase
    Á¤Áö±â [Go±â]
    [¿¾ ¿ë¾î] Á¤Áö±â
  • Proliferative phase
    Áõ½Ä±â
    [¿¾ ¿ë¾î] Áõ½Ä±â
  • Implantational phase
    Âø»ó±â
    [¿¾ ¿ë¾î] Âø»ó±â
  • Preimplantational phase
    Âø»óÀü±â
    [¿¾ ¿ë¾î] Âø»óÀü±â
  • Colostral phase
    ÃÊÀ¯±â
    [¿¾ ¿ë¾î] ÃÊÀ¯±â
  • Placental phase
    Źݱâ
    [¿¾ ¿ë¾î] Źݱâ
  • Involutional phase
    ÅðÈ­±â
    [¿¾ ¿ë¾î] ÅðÈ­±â
  • Proleptotene phase
    Dz¼¶À¯±â
    [¿¾ ¿ë¾î] Àü¼¼»ç±â
  • S phase
    ÇÕ¼º±â [S±â]
    [¿¾ ¿ë¾î] ÇÕ¼º±â
  • G1 phase
    ÇÕ¼ºÀü±â [G1±â]
    [¿¾ ¿ë¾î] ÀÏÂ÷ÈÞÁö±â
  • G2 phase
    ÇÕ¼ºÈıâ [G2±â]
    [¿¾ ¿ë¾î] ÀÌÂ÷ÈÞÁö±â
  • Ischemic phase
    ÇãÇ÷±â
    [¿¾ ¿ë¾î] ºóÇ÷±â
  • Luteal phase
    Ȳ(»ö)ü±â
    [¿¾ ¿ë¾î] Ȳü±â
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • tautomeric shift
    Åä¿ÀÅä¸ÓÀ̵¿(ì¹ÔÑ)
  • universal red shift
    °øÅë(Íì÷×) Àû»öÀ̵¿(îåßäì¹ÔÑ)
  • aqueous phase separator centrifugation
    ¾×»ó ºÐ¸®Ã¼ ¿ø½ÉºÐ¸® (äûßÒ ÝÂ×îô÷ êÀãýÝÂ×î)
  • carboxylation phase
    Ä«¸£º¹½ÇÈ­(ûù)±â(Ñ¢)
  • death phase
    »ç¸ê±â(ÞÝØþÑ¢)
  • decline phase
    "°¨Åð±â(Êõ÷ÜÑ¢), (ÔÒ) death phase"
  • effective lethal phase
    À¯È¿ Ä¡»ç±â(êóüùöÈÞÝÑ¢)
  • exponential phase
    Áö¼ö±â (ò¦â¦Ñ¢)
  • Gibbs phase rule
    ±é½º À§»ó ¹ýÄ¢(êÈßÓÛööÎ)
  • immobile phase
    °íÁ¤»ó(ͳïÒßÓ)
  • inductive phase
    À¯µµ±â(ë¯ÓôÑ¢)
  • lag phase
    Áöü½Ã±â(òÀôòãÁÑ¢)
  • lateral phase separation
    Ãø¸é»óºÐ¸®(ö°ØüßÀÝÂ×î)
  • log phase
    log ±â(Ñ¢)
  • maximum stationary phase
    ÃÖ´ëÁ¤Áö±â(õÌÓÞïÎò­Ñ¢)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • midline echo shift
    Á¤Áß¼±¿¡ÄÚº¯À§
  • pivot shift test
    ÃßÃà º¯À§½ÃÇè
  • shift
    º¯À§, ÀÚ¸®º¸³»±â, À̵¿, ½ÃÇÁÆ®
  • shift key
    ½ÃÇÁƮŰ
  • aliasing artifact
    ¿¡Àϸ®¾î½ÌÀΰø¹°
  • artefact;artifact
    Àΰø¹°, ÀΰøÀ½¿µ
  • artifact
    Àΰø¹°
  • beam harding artifact
    (X)¼±°æÈ­Àΰø¹°
  • beam width artifact
    ¼ÓÆøÀΰø¹°
  • central point artifact
    Áß½ÉÁ¡Àΰø¹°
  • comet tail artifact
    Çý¼º²¿¸®Àΰø¹°
  • crisscross artifact
    ±³Â÷Àΰø¹°
  • data clipping artifact
    ÀÚ·áÀý´ÜÀΰø¹°
  • duplication artifact
    Áߺ¹Àΰø¹°
  • edge ringing artifact
    º¯¿¬¿ï¸²Àΰø¹°
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
CSA Canadian Standards Association; canavaninosuccinic acid; carbonyl salicylamide; cell surface antigen...
CSI calculus surface index; cancer serum index; cavernous sinus infiltration; cervical spine injury; che...
CTS carpal tunnel syndrome; clinical trials support [program]; composite treatment score; computed tomog...
EDS edema disease of swine; egg drop syndrome; Ehlers-Danlos syndrome; Emery-Dreifus syndrome; energy-di...
EMSA electrophoretic mobility shift assay
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
EMSA Electrophoresis mobility shift assay
EMSA Electrophoretic Mobility Shift Assay
EMSA Electrophoretic gel mobility shift assay
EMS Electrophoretic mobility shift
EMSA Electrophoretic mobility shift analyses
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • shift ot left
    ÇÙ Á¹æ À̵¿
    È£Áß±¸ Áß À¯¾àÇüÀÇ °ÍÀ» ¿ÞÂÊ, ¼º¼÷ÇüÀÇ °ÍÀ» ¿À¸¥ÂÊ¿¡ µÎ¾î À¯¾àÇüÀÇ °ÍÀÌ ¸¹À¸¸é ÇÙ Á¹æ À̵¿À¸·Î Ç¥ÇöÇÑ´Ù.
  • shift system
    ±³´ëÁ¦ ±Ù¹«
    8½Ã°£ ÀÌ»óÀÇ ³ëµ¿À» ÇÊ¿ä·Î ÇÏ´Â Á÷Àå¿¡¼­ Á¶·Î ³ª´©¾î ÀÏÇÏ´Â Á¦µµ.
  • shift to right
    ¿ìÃø À̵¿
    Ç÷¾× »ó¿¡ À־ ¼º¼÷ Áß¼º±¸°¡ ¿ì¼¼ÇÑ °Í¿¡ ´ëÇÑ ArnethÀÇ ¿ë¾î.
  • shift to the right
    ¿ì¹æ À̵¿, ¿ì¹æ º¯À§, ¿ì°æ
    ÇÙ Á¹æ À̵¿ÀÇ ¹Ý´ë Çö»ó.
  • side-shift plate
    Bennett plates
    Whi
  • tube shift techique
    °ü±¸ À̵¿¼ú
  • aliasing artifact
    ¿¡Àϸ®¾î½Ì Àΰø¹°
  • beam harding artifact
    ¼± °æÈ­ Àΰø¹°
  • beam width artifact
    ¼Ó Æø Àΰø¹°
  • central point artifact
    Áß½ÉÁ¡ Àΰø¹°
  • duplication artifact
    Áߺ¹ Àΰø¹°, Áߺ¹ Çã»ó
  • ferromagnetic artifact
    öÀÚ¼º Àΰø¹°
  • herringbone artifact
    û¾î»À Àΰø¹°
  • image shading artifact
    ¿µ»ó Â÷±¤ Àΰø¹°
  • magnetic susceptibility artifact
    ÀÚ±âÈ­À² Àΰø¹°
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
doppler shift <radiobiology> The amount of change in the observed frequency of a wave due to the Doppler effect, sometimes called the Doppler frequency.
(09 Oct 1997)
threshold shift Measurement of the degree of hearing loss or impairment in terms of a decibel shift from an individual's previous audiogram.
(05 Mar 2000)
ym-shift <microbiology> The change in shape by dimorphic fungi when they shift from the yeast (Y) form in the animal body to the mould or mycelial form (M) in the environment.
(09 Oct 1997)
luteoplacental shift The change in site of production of the oestrogen and progesterone essential for human pregnancy from the corpus luteum to the placenta; ovariectomy always terminates pregnancy in most mammals because their placentas never produce enough oestrogen and progesterone, but, after the sixth week of pregnancy, a human placenta can produce enough of these hormones to prevent abortion despite ovariectomy.
(05 Mar 2000)
accelerated phase of leukaemia Refers to chronic myelogenous leukaemia that is progressing. The number of immature, abnormal white blood cells in the bone marrow and blood is higher than in the chronic phase, but not as high as in the blast phase.
(12 Dec 1998)
acceleration phase <cell biology, cell culture> A period of increasing growth before the log phase in a culture of microbes.
After the culture is started on a medium, at first there is no growth (the lag phase) and then the microbes start to gradually grow (acceleration phase) until they reach a constant maximum rate of growth (log phase).
(15 Jan 1998)
acute-phase protein <haematology> These plasma proteins (in addition to fibrinogen) increase 25% or more in response to inflammation and injury are under direct control of interleukin-6 (IL-6) (hepatocyte-stimulating factor).
Other proteins which increase are ceruloplasmin, C3 and C4 which increase 50% or more; alpha-1 acid glycoprotein, alpha-1 antitrypsin, haptoglobin and fibrinogen (the major determinant of viscosity 1 ) which increase two- to fourfold; C-reactive protein (CRP) and serum amyloid A which increase several hundred-fold.
Despite long-held clinical opinion to the contrary, available data indicate that neither ESR nor measurement of specific acute-phase reactants are useful in excluding underlying infection or inflammation regardless of the pretest probability.
These proteins are secreted into the blood in increased or decreased quantities by hepatocytes in response to trauma, inflammation, or disease. They can serve as inhibitors or mediators of the inflammatory processes. Certain acute-phase proteins have been used to diagnose and follow the course of diseases or as tumour markers.
See also: amyloid, c-reactive protein, erythrocyte sedimentation rate, viscosity.
(25 Jun 1999)
acute-phase reaction <immunology, rheumatology> Refers to the changes in synthesis of certain proteins within the serum during an inflammatory response, which provides rapid protection for the host against microorganisms via non-specific defense mechanisms.
It consists of fever, an increase in inflammatory humoral factors, and an increased synthesis by hepatocytes of a number of proteins or glycoproteins usually found in the plasma; the reaction is mediated by endogenous pyrogens, the hypothalamus, adrenal hormones, and other factors.
(12 Jul 2000)
anal phase In psychoanalytic personality theory, the stage of psychosexual development, occurring when a child is between 1 and 3 years, during which activities, interests, and concerns are centreed around the anal zone.
(05 Mar 2000)
aqueous phase The water portion of a system consisting of two liquid phase's, one mainly water, the other a liquid immiscible with water (e.g., benzene, ether).
(05 Mar 2000)
blast phase Refers to advanced chronic myelogenous leukaemia. In this phase, the number of immature, abnormal white blood cells in the bone marrow and blood is extremely high. Also called blast crisis.
(12 Dec 1998)
g0 phase Phase of the cell cycle where cells exist in a quiescent state. These cells have unduplicated DNA, degraded RNA and protein, and low enzyme activity. The ability to switch between g0 and g1 (and vice versa) determines the post-embryonic cell proliferation rate and is defectively controlled in neoplastic cells.
(12 Dec 1998)
g1 phase <cell biology, molecular biology> The period during interphase in the cell cycle between mitosis and the S phase (when DNA is replicated).
Also known as the decision period of the cell, because the cell decides to divide when it enters the s phase. The G stands for gap.
(09 Oct 1997)
g2 phase <cell biology, molecular biology> The period during interphase in the cell cycle between the S phase (when DNA is replicated) and mitosis (when the nucleus, then cell, divides).
at this time, the cell checks the accuracy of DNA replication and prepares for mitosis. The G stands for gap.
(09 Oct 1997)
radial growth phase The early pattern of growth of cutaneous malignant melanoma, in which tumour cells spread laterally in the epidermis.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 8 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • functional shift
    ±â´É Àüȯ
  • ghost shift
    ¹«ÀÎ ±³´ëÁ¦(Àΰ£ ´ë½Å ·Îº¿¸¸À¸·Î ÀÛ¾÷À» ÇÏ´Â °Í)
  • gliding shift
    FLEXTIME¿¡ ÀÇÇÑ ±³´ë ±Ù¹«(Á¦)
  • graveyard shift
    (3±³´ëÁ¦¿¡¼­)¹ä 12½Ã ºÎÅÍ ¿ÀÀü 8½Ã±îÁöÀÇ ±Ù¹«;±× ±Ù·ÎÀÚµé
  • night shift
    (ÁÖ¾ß ±³´ëÁ¦ÀÇ) ¾ß°£±Ù¹«;¾ß±Ù½Ã°£;¾ß±Ù ³ë¹«ÀÚ(Á¶)
  • red shift
    Àû»ö(Àû¹æ)ÆíÀÌ(µµÇ÷¯ È¿°ú³ª °­ÇÑ Áß·ÂÀÚÀ¸·Î ÀÎÇÑ)
  • shift
    ¹Ù²Ù´Ù;¿Å±â´Ù;¿òÁ÷ÀÌ´Ù;À̸®Àú¸® º¯µ¿ÇÏ´Ù;²Ù·Á³ª°¡´Ù;¼ÓÀÌ´Ù;(ÀÚµ¿Â÷ÀÇ ±â¾î¸¦)¹Ù²Ù´Ù;º¯°æ;º¯È­;±³´ë;¹æÃ¥;¼ÓÀÓ;Àӽú¯ÅëÀ¸·Î
  • swing shift
    (°øÀåÀÇ)¹Ý¾ß±Ù
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á